eprintid: 10051423
rev_number: 18
eprint_status: archive
userid: 608
dir: disk0/10/05/14/23
datestamp: 2018-07-03 08:57:00
lastmod: 2021-10-24 23:22:51
status_changed: 2018-07-03 08:57:00
type: article
metadata_visibility: show
creators_name: Fernström, E
creators_name: Minta, K
creators_name: Andreasson, U
creators_name: Sandelius, Å
creators_name: Wasling, P
creators_name: Brinkmalm, A
creators_name: Höglund, K
creators_name: Blennow, K
creators_name: Nyman, J
creators_name: Zetterberg, H
creators_name: Kalm, M
title: Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
ispublished: inpress
divisions: UCL
divisions: B02
divisions: C07
divisions: D07
divisions: F86
keywords: CSF biomarkers, cranial irradiation, neuronal damage, small-cell lung cancer
note: © 2018 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
abstract: BACKGROUND: Advances in the treatment of brain tumours have increased the number of long-term survivors, but at the cost of side effects following cranial radiotherapy ranging from neurocognitive deficits to outright tissue necrosis. At present, there are no tools reflecting the molecular mechanisms underlying such side effects, and thus no means to evaluate interventional effects after cranial radiotherapy. Therefore, fluid biomarkers are of great clinical interest. OBJECTIVE: Cerebrospinal fluid (CSF) levels of proteins involved in inflammatory signalling, synaptic plasticity and extracellular matrix (ECM) integrity were investigated following radiotherapy to the brain. METHODS: Patients with small-cell lung cancer (SCLC) eligible for prophylactic cranial irradiation (PCI) were asked to participate in the study. PCI was prescribed either as 2 Gy/fraction to a total dose of 30 Gy (limited disease) or 4 Gy/fraction to 20 Gy (extensive disease). CSF was collected by lumbar puncture at baseline, 3 months and 1 year following PCI. Protein concentrations were measured using immunobased assays or mass spectrometry. RESULTS: The inflammatory markers IL-15, IL-16 and MCP-1/CCL2 were elevated in CSF 3 months following PCI compared to baseline. The plasticity marker GAP-43 was elevated 3 months following PCI, and the same trend was seen for SNAP-25, but not for SYT1. The investigated ECM proteins, brevican and neurocan, showed a decline following PCI. There was a strong correlation between the progressive decline of soluble APPα and brevican levels. CONCLUSION: To our knowledge, this is the first time ECM-related proteins have been shown to be affected by cranial radiotherapy in patients with cancer. These findings may help us to get a better understanding of the mechanisms behind side effects following radiotherapy.
date: 2018-04-17
date_type: published
official_url: http://dx.doi.org/10.1111/joim.12763
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
article_type_text: Journal Article
verified: verified_manual
elements_id: 1550329
doi: 10.1111/joim.12763
lyricists_name: Zetterberg, Henrik
lyricists_id: HZETT94
actors_name: Bracey, Alan
actors_id: ABBRA90
actors_role: owner
full_text_status: public
publication: Journal of Internal Medicine
event_location: England
issn: 1365-2796
citation:        Fernström, E;    Minta, K;    Andreasson, U;    Sandelius, Å;    Wasling, P;    Brinkmalm, A;    Höglund, K;                 ... Kalm, M; + view all <#>        Fernström, E;  Minta, K;  Andreasson, U;  Sandelius, Å;  Wasling, P;  Brinkmalm, A;  Höglund, K;  Blennow, K;  Nyman, J;  Zetterberg, H;  Kalm, M;   - view fewer <#>    (2018)    Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy.                   Journal of Internal Medicine        10.1111/joim.12763 <https://doi.org/10.1111/joim.12763>.    (In press).    Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10051423/1/Cerebrospinal%20fluid%20and%20blood%20biomarkers%20for%20neurodegenerative%20dementias%20An%20update%20of%20the%20Consensus%20of%20the%20Task%20Force%20on%20Biological%20Markers%20in.pdf